CLX's revenue has rebounded to roughly $1.9B in the latest quarter, a 33.3% year-over-year gain flattered by a weak prior-year base, while gross margin has held in a 40.4% to 46.5% band.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue recovery and a 40-46% gross margin band are encouraging, but extreme quarterly swings in operating income, from a $235M loss to about $1.0B, suggest earnings are driven by one-time items rather than steady operating leverage.
Clorox offers a wide range of cleaning and disinfecting products, including wipes, sprays, and bleach, catering to diverse consumer needs for home hygiene.
The company's strong position in its product categories is a key driver, supported by its innovation-focused strategy and retailer relationships.
Clorox's commitment to innovation, sustainability, and making a positive impact underpins its brand strength and long-term growth potential.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 2, 2026 | $1.55+44.9% vs $1.07 | $1.9B+1.5% vs $1.9B |
Q3 2026 Aug 3, 2026 | $1.66+1.2% vs $1.64 | $1.9B+1.7% vs $1.9B |
Q2 2026 Apr 30, 2026 | $1.64+5.8% vs $1.55 | $1.7B+0.0% vs $1.7B |
Q1 2026 Feb 3, 2026 | $1.39-2.8% vs $1.43 | $1.7B+2.0% vs $1.6B |
Clorox (NYSE:CLX | CLX Price Prediction) reports fiscal first-quarter 2027 results on November 2. Shares trade at $87.52, and the $5 annualized dividend works out to a yield of about 5.7%.
Citizens Financial Group Inc. RI raised its position in shares of The Clorox Company (NYSE: CLX) by 346.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 24,187 shares of the company's stock after purchasing an additional 18,764 shares during the period.
Clorox reported net sales falling by 5%, and profits are falling by a larger percentage.
Clorox expects modest organic sales growth in fiscal 2027, but it'll absorb extra costs as it integrates a recent acquisition. Debt has doubled to about $5 billion.
Benchmark CLX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for The Clorox Company (CLX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $99.96 | $12.09B | 18.02 | -5.41% | 9.41% | 541.6% | 4.93% | |
| $109.33 | $25.91B | 33.68 | 1.57% | 12.41% | 18.21% | 1.08% | |
| $86.68 | $2.01B | 25.12 | -5.23% | 2.77% | 4.18% | 2.15% | |
| $23.84 | $1.63B | 20.24 | 2.28% | 2.73% | 47.41% | 5.07% | |
| $51.34 | $387.17M | 11.34 | 6.22% | 6.62% | 13.2% | 1.2% | |
| $165.40 | $385.15B | 24.84 | 3.26% | 18.23% | 29.42% | 2.55% |
The Clorox Company (CLX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
The Clorox Company (CLX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 2, 2026·SEC
Oct 29, 2026·SEC
Aug 3, 2026·SEC
Get notified when CLX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
The Clorox Company (CLX) stock FAQ — growth, dividends, profitability & financials explained
The Clorox Company (CLX) reported $7.20B in revenue over the trailing twelve months. Revenue was $6.72B in fiscal year 2026. That is 165% more than the $2.53B of fiscal year 1997.
The Clorox Company (CLX) grew revenue by 6.3% over the trailing twelve months, compared with the twelve months before.
Yes. The Clorox Company (CLX) earned $677.0M in net income over the trailing twelve months (a 9.4% net margin).
Yes. The Clorox Company (CLX) pays a dividend that yields 4.93% at the current price, a high yield.
The Clorox Company (CLX) had a return on equity (ROE) of 541.6% over the trailing twelve months. That is well above the market's typical 10-15%.
The Clorox Company (CLX) generated $453.0M in free cash flow over the trailing twelve months.
